Kohli, A., Osinusi, A., Sims, Z., Nelson, A., Meissner, E. G., Barrett, L. L., Bon, D., Marti, M. M., Silk, R., Kotb, C., Gross, C., Jolley, T. A., Sidharthan, S., Petersen, T., Townsend, K., Egerson, D., Kapoor, R., Spurlin, E., Sneller, M., Proschan, M., Herrmann, E., Kwan, R., Teferi, G., Talwani, R., Diaz, G., Kleiner, D. E., Wood, B. J., Chavez, J., Abbott, S., Symonds, W. T., Subramanian, G. M., Pang, P. S., McHutchison, J., Polis, M. A., Fauci, A. S., Masur, H., & Kottilil, S. (2015). virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study. Lancet, 385(9973), 1107–1113. http://access.bl.uk/ark:/81055/vdc_100042384952.0x000049